Lung Cancer | Specialty

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Making a Mark in Lung Cancer: An Interview With Roy S. Herbst, MD, PhD

October 4th 2011

Roy S. Herbst, MD, PhD, is a physician and translational researcher, whose work in developing novel, personalized therapies for lung cancer has helped drive significant changes in the way the disease is treated.

Oncogenic Signaling of the EGFR: Familiar Target Faces New Questions

October 3rd 2011

The epidermal growth factor receptor (EGFR) is the prototypical receptor tyrosine kinase (RTK) and one of the most comprehensively studied molecular targets in clinical oncology.

Welcome to UCD ChestHealth!

October 3rd 2011

Welcome to UCD ChestHealth, the official blog of UC Davis Thoracic Surgery.

Dr. Wakelee on Adjuvant Therapy Predictive Markers

September 30th 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center Discusses Adjuvant Therapy Predictive Markers

Novel PET Strategy May Predict Utility of Clinical Options

September 29th 2011

The desire to reduce the risk and severity of treatment-related toxicity by rapidly discontinuing ineffective therapy, and the increasing use of highly sensitive imaging technology.

Talactoferrin Shows Promise for Treatment of Severe Sepsis

September 28th 2011

The investigational oral agent talactoferrin alfa reduces the risk of death in patients being treated in the intensive care unit for severe sepsis.

Dr. Scagliotti on the Benefits of EGFR Targeted Therapy

September 27th 2011

Dr. Giorgio Scagliotti from the University of Turin in Italy on EGFR Targeted Therapy Survival Benefits

Dr. Yoneda Discusses Pulmonary Nodules

September 23rd 2011

Dr. Ken Y. Yoneda from UC Davis Cancer Center Discusses Pulmonary Nodules

Dr. Wakelee on Explaining Adjuvant Therapy to Patients

September 21st 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Explaining Adjuvant Therapy to Patients

The Caring Ambassadors Program

September 20th 2011

CAP is a nonprofit providing information, resource referrals for personal support, and public advocacy for people at risk for or living with lung cancer or hepatitis C.

Dr. Li Describes the Future of Lung Cancer Therapy

September 19th 2011

Dr. Tianhong Li from University of California Davis Cancer Center Describes the Future of Lung Cancer Therapy

Dr. Scagliotti Discusses EGFR Mutations in NSCLC

September 16th 2011

Dr. Giorgio Scagliotti from University of Turin Discusses EGFR Mutations in non-small cell lung cancer

Dr. Wakelee on Adjuvant Therapy in Elderly Patients

September 14th 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Adjuvant Therapy in Elderly NSCLC Patients

Dr. Scagliotti on Tailored Treatment & Host Genomics

September 13th 2011

Dr. Giorgio Scagliotti from the University of Turin on Tailored Treatment and the Cancer Genome

How Fellows Can Establish a Smoking Cessation Clinic

September 13th 2011

Cigarette smoking is the leading cause of preventable death in the United States, accounting for approximately 443,000 deaths, or 1 of every 5 deaths each year.

Dr. Yoneda Discusses Integrating the Pulmonologist

September 12th 2011

Dr.Ken Yoneda from UC Davis Cancer Center Discusses Integrating the Pulmonologist into Multidisciplinary Practice

Dr. Bradley Discusses Key Lung Cancer Topics

September 12th 2011

Dr. Jeffrey Bradley from Washington University School of Medicine Discusses Key Lung Cancer Topics

Dr. Li Discusses the EML4-ALK Fusion Gene

September 9th 2011

Dr. Tianhong Li from UC Davis Cancer Center Discusses the EML4-ALK Fusion Gene

Dr. Scagliotti Discusses the Future of Lung Cancer Therapy

September 8th 2011

Dr. Giorgio V. Scagliotti from the University of Turin Discusses the Future of Lung Cancer Therapy

Dr. Baas on the Standard of Care for Mesothelioma Patients

September 6th 2011

Dr. Paul Baas from the Netherlands Cancer Institute on the Standard of Care for Mesothelioma Patients